Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Aura Energy #Aura to IPO Swedish Vanadium prospect


Hikma Share Price (HIK)



Share Price Information for Hikma (HIK)


Share Price: 1,376.00Bid: 1,377.00Ask: 1,379.00Change: 0.00 (0.00%)No Movement on Hikma
Spread: 2.00Spread as %: 0.15%Open: 1,413.00High: 1,442.00Low: 1,368.00Yesterday’s Close: 1,376.00

Hikma Pharmaceuticals Plc Ord Shs 10P

Hikma is listed in the FTSE 250, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Hikma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
1376.00
Share Price SpacerBid
1377.00
Share Price SpacerAsk
1379.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
775,104
Share Price SpacerOpen
1,413.00
Share Price SpacerHigh
1,442.00
Share Price SpacerLow
1,368.00
Share Price SpacerClose
1,376.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 241.42m £3,321.91m 1,000

52 Week High 1,621.00 52 Week High Date 23-JUN-2017
52 Week Low 814.20 52 Week Low Date 1-MAR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1,824 230,460 168,825 -5.264 -261.39 25.45 1.85


London South East Users info for Hikma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Jun-18
17:47:08
1,430.143
733
Sell* 
1,429.50
1,431.00
10.48k
Trade Type:
Ordinary

22-Jun-18
16:53:15
1,429.805
761
Sell* 
1,429.50
1,431.00
10.88k
Trade Type:
Ordinary

22-Jun-18
16:53:05
1,430.14
100
Sell* 
1,429.50
1,431.00
1,430
Trade Type:
Ordinary




View more Hikma trades >>

Directors Deals for Hikma (HIK)
Trade DateActionNotifierPriceCurrencyAmountHolding
12-Jun-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Khalid Nabilsi held the position of CFO at Hikma Pharmaceuticals at the time of this trade.
 Khalid Nabilsi
012,842209700
30-May-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Said Darwazah held the position of Chairman and CEO at Hikma Pharmaceuticals at the time of this trade.
 Said Darwazah
052,16414956362
30-May-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Mazen Darwazah held the position of Executive Vice Chairman at Hikma Pharmaceuticals at the time of this trade.
 Mazen Darwazah
038,0883412058
View more Hikma directors dealings >>


Date/TimeUserSubject
Wed 22:41MulderHikma
7 Jun '18PianistaRE: Director/PDMR Shareholding RNS
7 Jun '18AlgebraicRE: suspended trade today?
7 Jun '18DoctorSsuspended trade today?
4 Jun '18enzo88Director/PDMR Shareholding RNS
31 May '18aamir718RE: Vote of confidence by CEO
30 May '18PianistaVote of confidence by CEO
18 May '18PianistaTrading update
18 May '18PokerchipsRE: Out now
18 May '18PokerchipsRE: Out now
17 May '18PianistaRE: Out now
17 May '18Jimbo1122RE: Out now
17 May '18aamir718RE: Out now
17 May '18Jimbo1122Out now
16 May '18DoctorSRE: Nice
16 May '18aamir718RE: Nice
16 May '18DoctorSRE: Nice
16 May '18ROIDSTERNice
10 May '18PokerchipsRE: Happy days not faraway
10 May '18aamir718RE: Happy days not faraway
3 May '18PokerchipsRE: Happy days not faraway
27 Apr '18aamir718Happy days not faraway
26 Apr '18PokerchipsRE: Unloved?
23 Apr '18FantomRE: Today's rise?
23 Apr '18PokerchipsRE: Today's rise?
View more share chat for Hikma (HIK) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.